Comparative efficacy, acceptability, and safety of medicinal, cognitive-behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple-treatments meta-analysis

References

• Death rates for 72 selected causes, by 5-year groups, race and sex: United States, 1979–1997. National Center for Health Statistics: Hyattsville, 2001
   Google Scholar
• US Food and Drug Administration. Relationship between psychotropic drugs and pediatric suicidality: review and evaluation of clinical data. 2005. Available at: http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf 2005 [Last accessed 10 January 2005]
   Google Scholar
• Lieberman JA. History of the use of antidepressants in primary care. Primary Care Companion J Clin Psychiatry 2003;5(Suppl 7):6-10
   PubMedGoogle Scholar
• Bridge JA, Birmaher B, Iyengar S, et al. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry 2009;166:42-9
   PubMed Web of Science ®Google Scholar
• Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007;297:1683-96
   PubMed Web of Science ®Google Scholar
• Cheung AH, Emslie GJ, Mayes TL. Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatr Allied Disciplines 2005;46:735-54
   PubMed Web of Science ®Google Scholar
• Weisz JR, McCarty CA, Valeri SM. Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull 2006;132:132-49
   PubMed Web of Science ®Google Scholar
• Walsh BT, Seidman SN, Sysko R, et al. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002;287:1840-7
   PubMed Web of Science ®Google Scholar
• March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive–behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA 2004;292:807-20
   PubMed Web of Science ®Google Scholar
• March J, Silva S, Curry J, et al. The Treatment for Adolescents with Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. Am J Psychiatry 2009;166:1141-9
   PubMed Web of Science ®Google Scholar
• Dubicka B, Elvins R, Roberts C, et al. Combined treatment with cognitive–behavioural therapy in adolescent depression: meta-analysis. Br J Psychiatry 2010;197:433-40
   PubMed Web of Science ®Google Scholar
• Hughes CW, Trivedi MH, Cleaver J, et al. DATE: depressed adolescents treated with exercise: study rationale and design for a pilot study. Ment Health Phys Act 2009;2:76-85
   PubMedGoogle Scholar
• MHRA Committee on Safety of Medicines Report of the CSM Expert Working Group on the safety of selective serotonin reuptake inhibitor antidepressants. 2005. Available at: http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf [Last accessed 15 June 2005]
   Google Scholar
• MHRA Committee on Safety of Medicines Selective serotonin reuptake inhibitors (SSRIs): overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents including a summary of available safety and efficacy data. 2006. Available at: http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&ssTargetNodeId=221&useSecondary=true&ssDocName=CON019494&showpage=1 [Last accessed 27 February 2006]
   Google Scholar
• Collaboration C. Review Manager (RevMan) Version 5.0 [computer program]. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008
   Google Scholar
• Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0. 0. [updated February 2008]. The Cochrane Collaboration 2008. Available at: www.cochrane-handbook.org [Last accessed 18 February 2013]
   Google Scholar
• Guy W. ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Washington, DC: US Department of Health, Education, and Welfare, 1976, pp 218-22
   Google Scholar
• Posner K, Oquendo M, Stanley B, Gould M. Suicidality Classification Project. 2007. Available at: http://www.fda.gov/ohrms/dockets/ac/04/slides/4006S1_08_Posner_files/frame.htm [Last accessed 19 February 2007]
   Google Scholar
• Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006;63:332-9
   PubMed Web of Science ®Google Scholar
• Cipriani A, Nosè M, Barbui C. What is a risk ratio? Epidemiologia e Psichiatria Sociale 2007;16:20-1
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Contr Clin Trials 1986;7:177-88
   PubMedGoogle Scholar
• Spiegelhalter DJ, Thomas A, Best N, et al. WinBUGS Version 1.4 User Manual. Cambridge: MRC Biostatistics Unit, 2003
   Google Scholar
• Giudici P, Givens GH, Mallick BK. Bayesian Modeling Using WinBUGS. Hoboken, NJ: John Wiley & Sons, 2009
   Google Scholar
• Salanti G, Higgins JP, Ades AE, et al. Evaluation of networks of randomized trials. Stat Meth Med Res 2008;17:279-301
   PubMed Web of Science ®Google Scholar
• Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol 2011;64:163-71
   PubMed Web of Science ®Google Scholar
• Salanti G, Marinho V, Higgins JP. A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. J Clin Epidemiol 2009;62:857-64
   PubMed Web of Science ®Google Scholar
• Ioannidis JP. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. Can Med Assoc J 2009;181:488-93
   PubMed Web of Science ®Google Scholar
• Simeon JG, Dinicola VF, Ferguson HB, et al. Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Progr Neuro Psychopharmacol Biol Psychiatry 1990;14:791-5
   PubMed Web of Science ®Google Scholar
• Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997;54:1031-7
   PubMed Web of Science ®Google Scholar
• Emslie GJ, Heiligenstein JH, Wagner KD, et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002;41:1205-15
   PubMed Web of Science ®Google Scholar
• Emslie G, Kratochvil C, Vitiello B, et al. Treatment for Adolescents with Depression Study (TADS): safety results. J Am Acad Child Adolesc Psychiatry 2006;45:1440-55
   PubMed Web of Science ®Google Scholar
• Mayes TL, Tao R, Rintelmann JW, et al. Do children and adolescents have differential response rates in placebo-controlled trials of fluoxetine? CNS Spectrums 2007;12:147-54
   PubMed Web of Science ®Google Scholar
• Rohde P, Silva SG, Tonev ST, et al. Achievement and maintenance of sustained response during TADS continuation and maintenance therapy. Arch Gen Psychiatry 2008;65:447
   PubMed Web of Science ®Google Scholar
• March JS, Silva S, Petrycki S, et al. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007;64:1132-43
   PubMed Web of Science ®Google Scholar
• Goodyer IM, Dubicka B, Wilkinson P, et al. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial. Health Technol Assess 2008;12:iii-iv, ix-60
   PubMed Web of Science ®Google Scholar
• Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40:762-72
   PubMed Web of Science ®Google Scholar
• Berard R, Fong R, Carpenter DJ, et al. An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder. J Child Adolesc Psychopharmacol 2006;16:59-75
   PubMed Web of Science ®Google Scholar
• Emslie GJ, Wagner KD, Kutcher S, et al. Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2006;45:709-19
   PubMed Web of Science ®Google Scholar
• Wagner KD, Ambrosini P, Rynn M, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA 2003;290:1033-41
   PubMed Web of Science ®Google Scholar
• Donnelly CL, Wagner KD, Rynn M, et al. Sertraline in children and adolescents with major depressive disorder. J Am Acad Child Adolesc Psychiatry 2006;45:1162-70
   PubMed Web of Science ®Google Scholar
• von Knorring AL, Olsson GI, Thomsen PH, et al. A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder. J Clin Psychopharmacol 2006;26:311-15
   PubMed Web of Science ®Google Scholar
• Wagner KD, Robb AS, Findling RL, et al. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 2004;161:1079-83
   PubMed Web of Science ®Google Scholar
• Wagner KD, Jonas J, Findling RL, et al. A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 2006;45:280-8
   PubMed Web of Science ®Google Scholar
• Emslie GJ, Ventura D, Korotzer A, et al. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry 2009;48:721-9
   PubMed Web of Science ®Google Scholar
• Emslie GJ, Findling RL, Yeung PP, et al. Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials. J Am Acad Child Adolesc Psychiatry 2007;46:479-88
   PubMed Web of Science ®Google Scholar
• Dubitsky GM. Review and evaluation of clinical data: placebo-controlled antidepressant studies in pediatric patients. Washington, DC: Food and Drug Administration. Available at: http://www.fda.gov/OHRMS/DOCKETS/ac/04/briefing/2004-4065b1-08-TAB06-Dubitsky-Review.pdf [Last accessed 6 August 2004]
   Google Scholar
• Hetrick SE, Merry SN, McKenzie J, et al. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Cochrane Database Syst Rev 2007;(3):CD004851. doi: 10.1002/14651858.CD004851.pub2
   Google Scholar
• Song F, Harvey I, Lilford R. Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions. J Clin Epidemiol 2008;61:455-63
   PubMed Web of Science ®Google Scholar
• Cooper NJ, Sutton AJ, Morris D, et al. Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Stat Med 2009;28:1861-81
   PubMed Web of Science ®Google Scholar
• Glenny AM, Altman DG, Song F, et al. Indirect comparisons of competing interventions. Health Technol Assess 2005;9:1-134, iii-iv
   PubMed Web of Science ®Google Scholar
• Cipriani A, Barbui C, Salanti G, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet 2011;378:1306-15
   PubMed Web of Science ®Google Scholar
• Song F, Altman DG, Glenny AM, et al. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 2003;326:472
   PubMed Web of Science ®Google Scholar
• Sneed JR, Rutherford BR, Rindskopf D, et al. Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry 2008;16:65-73
   PubMed Web of Science ®Google Scholar
• Usala T, Clavenna A, Zuddas A, et al. Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis. Eur Neuropsychopharmacol 2008;18:62-73
   PubMed Web of Science ®Google Scholar
• Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont) 2007;4:28-37
   PubMedGoogle Scholar